Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics**

https://doi.org/10.1016/S0029-7844(97)00309-8Get rights and content

Objective

To compare nicotine concentrations and fetal middle cerebral artery resistance indices (RIs) during 21-mg transdermal nicotine use with these values during maternal smoking.

Methods

In this randomized, crossover study, participants smoked approximately 20 cigarettes daily and were between 24 and 36 weeks' gestation. Subjects were randomized to transdermal nicotine or to smoking ad libitum for 8 hours. One week later, they crossed over to the other condition. Maternal plasma nicotine concentrations and hemodynamic measurements were obtained before and after the onset of smoking or patch placement.

Results

Area under the plasma nicotine concentration time curve during patch use was similar to continued smoking (93 versus 89 ng-hour/mL, respectively) (P = .77). The mean (standard error [SE] change in the middle cerebral artery RI from baseline to 4 hours later was similar during patch use and smoking: −.002 (0.008) versus −.02 (0.015) respectively (P = .3). The study had greater than 80% power to detect a 25% difference in nicotine concentrations and a change of 2 standard deviations in the middle cerebral artery RI between conditions. An unexpected finding was that of a loss of fetal heart rate (FHR) reactivity in 5/8 tracings after patch placement versus 1/6 tracings after smoking (P = .12) The baseline FHR increased by a mean (SE) of 8 (4) beats per minute with loss of reactivity in the patch condition, compared with a decrease of 3 (3) beats per minute without loss of reactivity (P = .05).

Conclusion

Eight-hour use of 21-mg transdermal nicotine yields nicotine concentrations and middle cerebral artery RIs similar to those produced by hourly smoking in pregnant smokers.

References (22)

  • LeopoldGR

    Antepartum obstetrical ultrasound examination guidelines

    J Ultrasound Med

    (1986)
  • Cited by (70)

    • The effect of ethanol and nicotine on ER stress in human placental villous explants

      2022, Current Research in Toxicology
      Citation Excerpt :

      The effects of nicotine on placental physiology, e.g. on placental blood flow have been studied in animals (Birnbaum et al., 1994) and in human placental perfusion (Bainbridge and Smith, 2006), but molecular toxicity in human placental tissue has not yet been studied. Nicotine serum concentrations when smoking cigarette or using nicotine replacement therapy may vary between 25 nm and 25 µM (DeVeaugh-Geiss et al., 2010; Massadeh et al., 2009; Oncken et al., 1997) and 2‰ ethanol corresponds to state where clinical symptoms include e.g., confusion, impaired balance, and slurred speech. In this study we used dose levels of nicotine (15 µM) and ethanol (2‰) that corresponds to the worst-case scenario of tobacco smoking and alcohol use (Skurtveit et al., 2002; Massadeh et al., 2009).

    • Residual Risk of Nicotine

      2021, Toxicological Evaluation of Electronic Nicotine Delivery Products
    • Prenatal nicotine exposure in rhesus monkeys compromises development of brainstem and cardiac monoamine pathways involved in perinatal adaptation and sudden infant death syndrome: Amelioration by Vitamin C

      2011, Neurotoxicology and Teratology
      Citation Excerpt :

      Pumps were implanted under ketamine anesthesia and were changed every three weeks to maintain a steady-state infusion throughout pregnancy; minipump changes were carried out under the direction of a veterinary surgeon following strict sterile protocols. This regimen produces maternal plasma levels of about 30 ng/ml for nicotine and 120 for cotinine (Slotkin et al., 2005), both well within the range of values typical of maternal smoking in pregnant smokers consuming 10–20 cigarettes per day (Ogburn et al., 1999; Slotkin et al., 2005), importantly, total nicotine delivery and average daily nicotine plasma levels are similar in pregnant smokers and in users of transdermal nicotine patches (Oncken et al., 1997). Concurrently with the nicotine or vehicle infusion, animals received daily oral supplementation with Vitamin C in the form of a chewable vitamin pill; there were four different Vitamin C dose levels (0, 50, 100, and 250 mg per day).

    View all citing articles on Scopus
    **

    Hoechst-Marion-Roussel (Kansas City, MO) supported this study with a grant-in-aid. The study also was funded by an NIH General Clinical Research Center grant (M01RR06192). The authors thank Drs. Jonathan Clive and Kevin Sweeney for performing statistical analysis.

    View full text